D-0124-2020 Class II Ongoing
FDA drug recall D-0124-2020 was initiated by Torrent Pharma Inc. on Sep 19, 2019 and is designated Class II. Reason for recall: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million. The recall status is ongoing. Affected quantity: 8,688 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 9, 2019
- Initiation Date
- Sep 19, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,688 bottles
Product description
Losartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 tablets per bottle, Rx Only, Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC: 13668-118-90
Reason for recall
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million.
Distribution pattern
Nationwide USA and Puerto Rico
Code information
Lot 4P04D007
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0124-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026